Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients with systemic lupus erythematosus.

Shah M, Chaudhari S, McLaughlin TP, Kan HJ, Bechtel B, Dennis GJ, Molta CT.

Clin Ther. 2013 Apr;35(4):486-97. doi: 10.1016/j.clinthera.2013.03.001.

PMID:
23587268
2.

Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review.

Sarnes E, Crofford L, Watson M, Dennis G, Kan H, Bass D.

Clin Ther. 2011 Oct;33(10):1413-32. doi: 10.1016/j.clinthera.2011.09.009. Epub 2011 Oct 13. Review.

PMID:
21999885
3.

Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Bhangle SD, Kramer N, Rosenstein ED.

Rheumatol Int. 2013 Aug;33(8):1923-32. doi: 10.1007/s00296-013-2750-z. Epub 2013 Apr 16. Review.

PMID:
23588411
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
5.

A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors.

Nevskaya T, Gamble MP, Pope JE.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):700-710. Epub 2017 Feb 24. Review.

PMID:
28240590
6.

A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.

Slawsky KA, Fernandes AW, Fusfeld L, Manzi S, Goss TF.

Arthritis Care Res (Hoboken). 2011 Sep;63(9):1224-32. doi: 10.1002/acr.20502. Review.

7.

Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis.

Wang LR, Barber CE, Johnson AS, Barnabe C.

Semin Arthritis Rheum. 2014 Dec;44(3):325-30. doi: 10.1016/j.semarthrit.2014.06.001. Epub 2014 Jun 26. Review.

PMID:
25129259
8.

The efficacy of antimalarials in systemic lupus erythematosus.

Esdaile JM.

Lupus. 1993 Feb;2 Suppl 1:S3-8. Review.

PMID:
8485568
9.

The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use.

Manson SC, Brown RE, Cerulli A, Vidaurre CF.

Respir Med. 2009 Jul;103(7):975-94. doi: 10.1016/j.rmed.2009.01.003. Epub 2009 Apr 15. Review.

10.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

11.

Belimumab: review of use in systemic lupus erythematosus.

Boyce EG, Fusco BE.

Clin Ther. 2012 May;34(5):1006-22. doi: 10.1016/j.clinthera.2012.02.028. Epub 2012 Mar 30. Review.

PMID:
22464040
12.

Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review.

Chen HS, Tsai WP, Leu HS, Ho HH, Liou LB.

Rheumatology (Oxford). 2007 Mar;46(3):539-44. Epub 2006 Oct 13. Review.

PMID:
17043051
13.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
14.

Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight.

Doria A, Gatto M, Iaccarino L, Punzi L.

Lupus. 2015 Apr;24(4-5):507-15. doi: 10.1177/0961203314559087. Review.

PMID:
25801894
15.

Corticosteroids in Lupus.

Kasturi S, Sammaritano LR.

Rheum Dis Clin North Am. 2016 Feb;42(1):47-62, viii. doi: 10.1016/j.rdc.2015.08.007. Review.

PMID:
26611550
16.

Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider.

Turchetti G, Yazdany J, Palla I, Yelin E, Mosca M.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S116-22. Epub 2012 Oct 16. Review.

17.

Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials.

Sciascia S, Mompean E, Radin M, Roccatello D, Cuadrado MJ.

Clin Drug Investig. 2017 Jun;37(6):519-524. doi: 10.1007/s40261-017-0518-z. Review.

PMID:
28357813
18.

Adverse neuropsychological effects associated with cumulative doses of corticosteroids to treat childhood acute lymphoblastic leukemia: A literature review.

Pépin AJ, Cloutier-Bergeron A, Malboeuf-Hurtubise C, Achille M, Krajinovic M, Laverdière C, Lippé S, Marcoux S, Sinnett D, Sultan S.

Crit Rev Oncol Hematol. 2016 Nov;107:138-148. doi: 10.1016/j.critrevonc.2016.09.001. Epub 2016 Sep 9. Review.

PMID:
27823641

Supplemental Content

Support Center